Stocks Health care MCK
NYSE · Health careMcKesson Corp (MCK)
McKesson Corp brought in $411B of revenue over the twelve months to June 30, 2026, up 8.8% from a year earlier. Net income was $4.6B, a net margin of 1.1%. Operating cash flow minus capital spending left $5.7B of free cash flow in fiscal 2026. At June 30, 2026 it held $5.2B in cash against $9.7B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 5, 2026.
What McKesson Corp does
McKesson distributes pharmaceuticals, medical supplies, and healthcare technology solutions. It sells prescription drugs and care management tools to retail pharmacies, hospitals, clinics, and health systems. It is known for managing medical supply chains across North America. Its shares trade on NYSE under the ticker MCK.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2026 | $403.4B | $4.8B | $38.38 | $5.7B |
| 2025 | $359.1B | $3.3B | $25.72 | $5.5B |
| 2024 | $309B | $3B | $22.39 | $3.9B |
| 2023 | $276.7B | $3.6B | $25.03 | $4.8B |
| 2022 | $264B | $1.1B | $7.23 | $4B |
| 2021 | $238.2B | -$4.5B | -$28.26 | $4.1B |
Where MCK ranks in Health care
Dividends
McKesson Corp declared $3.17 per share in fiscal 2026. At the current price that is a yield of 0.37%. It paid out $381M in cash dividends, 8% of its net income.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2026 | $3.17 | $381M | 8% |
| 2025 | $2.75 | $345M | 10% |
| 2024 | $2.40 | $314M | 10% |
| 2023 | $2.09 | $292M | 8% |
| 2022 | $1.83 | $277M | 25% |
| 2021 | $1.67 | $276M | n/a |
Latest SEC filings
What McKesson Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 28, 2026
- August 5, 2026Quarterly report 10-Q · period to June 30, 2026
- August 5, 2026
- July 24, 2026
- July 1, 2026
- June 30, 2026Additional proxy material DEFA14A
- June 12, 2026
- June 12, 2026Additional proxy material DEFA14A
- June 12, 2026Proxy statement DEF 14A
- June 12, 2026
What is MCK worth? A DCF from its reported cash flow
Insider trades
What the people running McKesson Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $99K worth of shares in the last 90 days and bought none on the open market. All of the selling was pre-planned under Rule 10b5-1 trading plans.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 8, 2026 | Rutledge Napoleon B JRSVP, Controller & CAO | Soldpre-planned (10b5-1) | 111 | $99K |
Questions about MCK
What does McKesson Corp do?
McKesson distributes pharmaceuticals, medical supplies, and healthcare technology solutions. It sells prescription drugs and care management tools to retail pharmacies, hospitals, clinics, and health systems. It is known for managing medical supply chains across North America. Its shares trade on NYSE under the ticker MCK.
Is McKesson Corp profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $4.6B on revenue of $411B, a net margin of 1.1%.
How much revenue does McKesson Corp make?
Over the twelve months to June 30, 2026 McKesson Corp reported revenue of $411B. That is 8.8% more than a year earlier.
When did McKesson Corp last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 5, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 10, 2026.
Similar companies
Compare MCK with
Follow MCK
Get an email when McKesson Corp files with the SEC: results, executive changes, material agreements and annual reports.
Follow MCK: get an email when it filesWhere the numbers come from
Financial figures are the values McKesson Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.